These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8821312)

  • 21. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the duration of illness before treatment affect the time taken to recover on treatment in severely depressed women?
    Wilkinson P; Hawton K; Andrew B; Fagg J
    J Affect Disord; 1996 Nov; 41(2):89-92. PubMed ID: 8961035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD; Shults J
    J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug treatment of depression in frail elderly nursing home residents.
    Streim JE; Oslin DW; Katz IR; Smith BD; DiFilippo S; Cooper TB; Ten Have T
    Am J Geriatr Psychiatry; 2000; 8(2):150-9. PubMed ID: 10804076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lithium augmentation in a case of renal impairment: risk vs. benefit.
    Gash AJ; Chhabra S; Eccleston D
    J Affect Disord; 1995 Apr; 34(1):51-3. PubMed ID: 7622739
    [No Abstract]   [Full Text] [Related]  

  • 26. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.
    Inoue T; Tsuchiya K; Miura J; Sakakibara S; Denda K; Kasahara T; Koyama T
    Biol Psychiatry; 1996 Jul; 40(2):151-3. PubMed ID: 8793048
    [No Abstract]   [Full Text] [Related]  

  • 28. Relapse of depressed patients after effective continuation therapy.
    Georgotas A; McCue RE
    J Affect Disord; 1989; 17(2):159-64. PubMed ID: 2527891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of mood changes and antidepressants on the cognitive capacity of elderly depressed patients.
    Georgotas A; McCue RE; Reisberg B; Ferris SH; Nagachandran N; Chang I; Mir P
    Int Psychogeriatr; 1989; 1(2):135-43. PubMed ID: 2491140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation strategies in patients with refractory depression.
    Nemeroff CB
    Depress Anxiety; 1996-1997; 4(4):169-81. PubMed ID: 9166649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Pisa syndrome (pleurothotonus) during antidepressant therapy.
    Suzuki T; Kurita H; Hori T; Sasaki M; Baba A; Shiraishi H; Piletz JE
    Biol Psychiatry; 1997 Jan; 41(2):234-6. PubMed ID: 9018396
    [No Abstract]   [Full Text] [Related]  

  • 34. Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy?
    Buysse DJ; Reynolds CF; Houck PR; Perel JM; Frank E; Begley AE; Mazumdar S; Kupfer DJ
    J Clin Psychiatry; 1997 Oct; 58(10):426-32. PubMed ID: 9375592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder.
    Papakostas GI; Petersen T; Denninger JW; Montoya HD; Nierenberg AA; Alpert JE; Fava M
    Ann Clin Psychiatry; 2003; 15(3-4):187-92. PubMed ID: 14971864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants.
    Flint AJ; Rifat SL
    Am J Psychiatry; 1999 Jun; 156(6):943-5. PubMed ID: 10360137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extreme suicidality following serotonin syndrome.
    Serfaty MA; McCluskey S; Eccleston D
    Br J Psychiatry; 1995 Sep; 167(3):410. PubMed ID: 7496659
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antidepressive agents in the elderly].
    de Hooge JK
    Tijdschr Gerontol Geriatr; 1990 Dec; 21(6):259-67. PubMed ID: 1980385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of antidepressant trials: clinical and research implications.
    Donovan SJ; Quitkin FM; Stewart JW; Ocepek-Welikson K; Harrison W; McGrath PJ; Nunes EV; Wager S; Tricamo E
    J Clin Psychopharmacol; 1994 Feb; 14(1):64-6. PubMed ID: 8151005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.